Myeloid-derived suppressor cells in ovarian cancer: friend or foe?

Although previous decades contributed to major progress in targeted therapy of many malignancies, the treatment of gynaecological cancers remains a challenging task. In the evidence of rising cancer mortality, the search for new methods of treatment is a dire need. Exploring the mechanisms of intera...

Descripción completa

Detalles Bibliográficos
Autores principales: Walankiewicz, Monika, Grywalska, Ewelina, Polak, Grzegorz, Kotarski, Jan, Siwicka-Gieroba, Dorota J., Roliński, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Society of Experimental and Clinical Immunology 2017
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820985/
https://www.ncbi.nlm.nih.gov/pubmed/29472817
http://dx.doi.org/10.5114/ceji.2017.72823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820985/
https://www.ncbi.nlm.nih.gov/pubmed/29472817
http://dx.doi.org/10.5114/ceji.2017.72823

Ejemplares similares